Calling the device "dangerous" is over the top. While the subjects of prior trials who didn't respond well to the device may have fared better with a more typical treatment, we're talking about a matter of a few days. The device was their best chance for longer- term survival, and they signed up for the trial in hopes of achieving just that. The detractors make it sound like healthy people are being killed by this device. In truth, almost dead people died. The other treatments would have bought a few more days at best. We're talking about people who need a liver transplant, and there are not enough livers to go around. This is why every effort is being made to see whom ELAD will benefit, with the FDA's blessing. Success is necessary!
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM